Studies from Nanchang University Yield New Information about Heart Failure (The Efficacy and Safety of Sacubitril-valsartan for the Treatment of Heart Failure In Adults: a Meta-analysis).

A meta-analysis conducted by researchers at Nanchang University in Jiangxi, China, examined the effectiveness and safety of sacubitril-valsartan (SV) as a treatment for heart failure. The analysis included ten randomized controlled trials with a total of 18,164 heart patients. The results showed that SV was effective in reducing the number of heart patients and had minimal risk and side effects compared to control drugs. The researchers concluded that SV is an effective treatment for heart failure, reducing hospitalization and cardiovascular mortality. [Extracted from the article]